Lee, I., Mitsumoto, H., Lee, S., Kasarskis, E., Rosenbaum, M., Factor‐Litvak, P., & Nieves, J. W. (2025). Interaction between riluzole treatment and dietary glycemic index in the disease progression of amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. Portico. https://doi.org/10.1002/acn3.52294

Utkina-Sosunova, I., Chiorazzi, A., de Planell-Saguer, M., Li, H., Meregalli, C., Pozzi, E., Carozzi, V. A., Canta, A., Monza, L., Alberti, P., Fumagalli, G., Karan, C., Moayedi, Y., Przedborski, S., Cavaletti, G., & Lotti, F. (2024). Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-70294-w

Shukla, A. G., Cioffi, G. A., & Liebmann, J. M. (2024). Drug-Induced Liver Injury During a Glaucoma Neuroprotection Clinical Trial. Journal of Glaucoma, 33(8), e58–e59. https://doi.org/10.1097/ijg.0000000000002394

Thakore, N. J., Lapin, B. R., Mitsumoto, H., & Pooled Resource Open‐Access ALS Clinical Trials Consortium. (2022). Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis. Muscle & Nerve, 66(6), 702–708. Portico. https://doi.org/10.1002/mus.27724

Chen, X., Zhang, J., Wu, Y., Tucker, R., Baird, G. L., Domonoske, R., Barrios-Anderson, A., Lim, Y.-P., Bath, K., Walsh, E. G., & Stonestreet, B. S. (2022). Inter-alpha Inhibitor Proteins Ameliorate Brain Injury and Improve Behavioral Outcomes in a Sex-Dependent Manner After Exposure to Neonatal Hypoxia Ischemia in Newborn and Young Adult Rats. Neurotherapeutics, 19(2), 528–549. https://doi.org/10.1007/s13311-022-01217-8